Reinnervate Expands Its Distribution Network For Alvetex®

Printer-friendly versionPDF version

Reinnervate is delighted to announce it has signed agreements with seven new European distributors for the non-exclusive distribution of alvetex®

Reinnervate, the emerging global leader in the rapidly growing 3D cell culture market, is delighted to announce it has signed agreements with seven new European distributors for the non-exclusive distribution of alvetex^®, its breakthrough 3D cell culture technology.
 
These agreements mark a significant expansion of reinnervate’s distribution network. Under the terms of the new agreements, alvetex^® will be distributed and sold under the reinnervate brand by leading regional distributors of life sciences research products -  Generon (UK), Biozol GmbH (Germany), Chemie Brunschwig AG (Switzerland), THP Medical Products (Austria), In Vitro AS (Denmark), Euroclone (Italy) and Bio Connect (the Benelux region).
 
Following the recent expansion of reinnervate’s distribution network in Asia and Australia the appointment of these new distributors further increases the company’s global reach, enabling more researchers to directly access the multi award winning alvetex^® 3D technology platform . 
 
Richard Rowling, Commercial Director of reinnervate, commented: “The limitations of traditional cell culture techniques to generate biologically-relevant in vitro models are well documented.  Alvetex^® 3D cell culture products help to overcome these limitations and the expansion of our European sales footprint is an important step towards our goal of making it easy for customers in every country to access alvetex products, services and support.”
 
Researchers wishing to purchase alvetex^® can do via the reinnervate web portal at http://www.reinnervate.com/alvetex/order